DKK1 and osteogenesis imperfecta type 3: Specifically, following treatment, OI type III samples had a significantly greater upregulation in TWIST1 (TRL and TRH), SOST (TRL and TRH), and DKK1 (TRL) above non‐OI untreated control levels.